Original Articles

Serum Ferritin as a Predictive Biomarker for Glycemic Control in Type 2 Diabetes; A Cross-sectional Analysis

  1. Consultant Chemical Pathologist, Bakhtawar Amin Medical and Dental College, Multan
  2. Registrar Microbiology CMH Multan
  3. Final Year Resident Radiology, CMH Quetta,
  4. Final Year Resident General Surgery, CMH Quetta
  5. Registrar Orthopaedic Surgery, RTEH Muzaffargarh
  6. Final Year Resident Urology, MIKD Multan
https://doi.org/10.48036/apims.v20i4.1120

Abstract

Objective to determine whether serum ferritin is associated with glycemic control, measured by HbA1c, in Pakistani adults with T2DM.

Methodology: A descriptive cross-sectional study was conducted at Nishtar Medical University/Hospital, Multan, from 24 August 2022 to 24 February 2023. Consecutive adults aged 30–70 years with physician-diagnosed T2DM of >2 years’ duration were enrolled (n = 151). Patients on iron therapy, with anemia, acute infection, blood donation, pregnancy, or chronic renal/hepatic disease were excluded. Serum ferritin (chemiluminescent immunoassay) and HbA1c (HPLC) were measured. Elevated ferritin was defined as >250 ng/mL in males or >120 ng/mL in females. Correlations were assessed with Spearman’s ?; chi-square tests were used post-stratification. Significance was set at p ? 0.05.

Results: Mean age was 48.8 ± 10.8 years; 57.0 % were female. Median HbA1c was 7.7 % (IQR 3.3); 58.9 % (n = 89) had uncontrolled diabetes (HbA1c ? 7 %). Median ferritin was 96 ng/mL (IQR 131), with elevated levels in 30.5 % of participants. HbA1c correlated positively with ferritin (? = 0.252, p = 0.002). Elevated ferritin was more common in uncontrolled versus controlled diabetes (44.9 % vs 9.7 %; p < 0.001). The HbA1c-ferritin correlation remained significant among females, obese patients, rural residents, non-hypertensive individuals, and those without a family history of hypertension.

Conclusions: Serum ferritin is independently associated with poorer glycemic control in Pakistani adults with T2DM and may serve as a practical adjunct biomarker for risk stratification in routine care. Prospective studies are needed to validate its predictive value and explore therapeutic strategies targeting iron overload.

Keywords: Serum ferritin, Type 2 diabetes mellitus, Glycemic control, Biomarker

Metrics

288Abstract views
255Downloads

Full Text

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue